ReGenesys is a wholly owned subsidiary of Athersys Inc. (NASDAQ: ATHX), a publicly held biotechnology company in Cleveland, Ohio.

Athersys is developing MultiStem® cell therapy, a patented, adult-derived, “off-the-shelf” stem cell product. ReGenesys is focused on the R&D that supports the MultiStem® clinical programs and is developing potential new regenerative medicine opportunities, such as animal health care.